Nivolumab adverse events?

What are common side effects of Nivolumab?

Nivolumab is a cancer immunotherapy medication known for its potential to cause various adverse events. According to clinical data, some common side effects include [1]:

* Fatigue (40-50% of patients)
* Diarrhea (30-40% of patients)
* Nausea (30-40% of patients)
* Vomiting (20-30% of patients)
* Pruritus (itching) (20-30% of patients)
* Rash (15-25% of patients)

More severe side effects to be aware of:

Less common but more serious side effects of Nivolumab include [2]:

* Immune-mediated pneumonitis (inflammation of the lungs) (3-5% of patients)
* Colitis (inflammation of the colon) (2-4% of patients)
* Hepatitis (inflammation of the liver) (2-4% of patients)
* Hypophysitis (inflammation of the pituitary gland) (1-3% of patients)
* Thyroiditis (inflammation of the thyroid gland) (1-2% of patients)

What to do if you experience side effects:

If you experience any side effects while taking Nivolumab, it is essential to report them to your healthcare provider. They can help manage the side effects and adjust your treatment plan as needed.

Monitoring and precautions:

To minimize the risk of serious side effects, patients taking Nivolumab should be closely monitored by their healthcare provider. This includes regular blood tests, physical exams, and imaging studies to detect any signs of immune-mediated adverse events.

Sources:
[1] https://www.drugpatentwatch.com/drugs/Opdivo-nivolumab/
[2] https://www.opdivo.com/safety-and-efficacy/side-effects/